The estimated net worth of Mr. Danny L. Dearen is at least $37,980,812 as of 29 Sep 2023. He has earned $33,547,412
from insider trading and has received compensation worth at least
$4,433,400 in Axonics, Inc..
What is the salary of Danny L. Dearen?
Mr. Danny L. Dearen salary is $738,900 per year
as Pres & Chief Financial Officer in Axonics, Inc..
How old is Danny L. Dearen?
Mr. Danny L. Dearen is 62 years old, born in 1963.
What stocks does Danny L. Dearen currently own?
As insider, Mr. Danny L. Dearen owns shares in one company:
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
Mr. Danny L. Dearen has made 56 insider trades between 2019-2023, according to the Form 4 filled with the SEC. Most recently he sold
7,675 units of AXNX stock worth $436,493 on 29 Sep 2023.
The largest trade he's
ever made was exercising 75,000 units of AXNX stock
on 20 Apr 2021. As of 29 Sep 2023
he still owns at least 23,777 units of AXNX stock.
Transaction
Date
Security
Shares
Price per share
Total value
Source
Sale
Common Stock
7,675
$56.87
$436,493
Option
Performance-Based Restricted Stock Units
11,250
N/A
N/A
Option
Common Stock
11,250
N/A
N/A
Sale
Common Stock
300
$50.14
$15,042
Sale
Common Stock
7,699
$49.44
$380,608
Option
Common Stock
13,208
$14.19
$187,422
Sale
Common Stock
9,637
$60.5
$583,077
Sale
Common Stock
10,363
$59.93
$621,065
Option
Stock Options (Right to buy)
13,208
$14.19
$187,422
Option
Common Stock
2,001
$14.19
$28,394
Sale
Common Stock
2,001
$60.01
$120,072
Option
Stock Options (Right to buy)
2,001
$14.19
$28,394
Option
Common Stock
2,899
$1.63
$4,725
Sale
Common Stock
7,802
$55.68
$434,408
Option
Common Stock
5,468
$25.82
$141,184
Option
Stock Options (Right to buy)
2,899
$1.63
$4,725
Option
Stock Options (Right to buy)
5,468
$25.82
$141,184
Option
Stock Options (Right to buy)
6,633
$14.19
$94,122
Sale
Common Stock
7,198
$54.84
$394,702
Option
Common Stock
6,633
$14.19
$94,122
Sale
Common Stock
474
$60.44
$28,646
Sale
Common Stock
2,772
$61.02
$169,136
Option
Performance-Based Restricted Stock Units
20,000
N/A
N/A
Option
Common Stock
25,250
N/A
N/A
Sale
Common Stock
2,720
$61.12
$166,252
Sale
Common Stock
7,791
$61.17
$476,568
Sale
Common Stock
656
$75.6
$49,594
Sale
Common Stock
6,960
$72.19
$502,428
Sale
Common Stock
26,760
$70.33
$1,881,924
Option
Common Stock
7,047
$14.19
$99,997
Option
Common Stock
1,616
$1.32
$2,133
Option
Stock Options (Right to buy)
7,047
$14.19
$99,997
Option
Common Stock
2,044
$1.32
$2,698
Option
Stock Options (Right to buy)
20,545
$1.63
$33,488
Option
Common Stock
20,545
$1.63
$33,488
Sale
Common Stock
16,280
$71.26
$1,160,178
Option
Common Stock
6,250
$25.82
$161,375
Option
Stock Options (Right to buy)
6,250
$25.82
$161,375
Option
Stock Options (Right to buy)
12,329
$25.82
$318,335
Sale
Common Stock
1,500
$56.32
$84,476
Sale
Common Stock
7,846
$57.4
$450,321
Option
Common Stock
12,329
$25.82
$318,335
Sale
Common Stock
10,564
$58.11
$613,916
Option
Common Stock
3,579
$14.19
$50,786
Option
Stock Options (Right to buy)
3,579
$14.19
$50,786
Sale
Common Stock
10,000
$57
$570,000
Option
Stock Options (Right to buy)
6,421
$25.82
$165,790
Option
Common Stock
6,421
$25.82
$165,790
Option
Stock Option (Right to Buy)
20,000
$14.19
$283,800
Sale
Common Stock
947
$49.04
$46,436
Sale
Common Stock
17,737
$48.21
$855,101
Option
Common Stock
36,919
N/A
N/A
Option
Performance-Based Restricted Stock Units
26,086
N/A
N/A
Sale
Common Stock
3,730
$48.26
$179,999
Sale
Common Stock
2,017
$46.83
$94,452
Option
Common Stock
20,000
$14.19
$283,800
Sale
Common Stock
13,853
$49.07
$679,725
Sale
Common Stock
400
$49.7
$19,878
Sale
Common Stock
2,046
$52.61
$107,632
Option
Common Stock
3,718
$1.42
$5,280
Sale
Common Stock
4,312
$49.73
$214,427
Option
Common Stock
5,477
$1.63
$8,928
Option
Stock Option (Right to Buy)
5,477
$1.63
$8,928
Option
Common Stock
10,805
$14.19
$153,323
Option
Stock Option (Right to Buy)
10,805
$14.19
$153,323
Sale
Common Stock
9,756
$50.8
$495,644
Option
Stock Option (Right to Buy)
3,718
$1.42
$5,280
Sale
Common Stock
3,886
$51.68
$200,832
Option
Common Stock
6,866
$1.48
$10,127
Option
Stock Option (Right to Buy)
6,866
$1.48
$10,127
Option
Common Stock
6,866
$1.48
$10,127
Option
Stock Option (Right to Buy)
6,866
$1.48
$10,127
Sale
Common Stock
6,866
$55.22
$379,161
Option
Common Stock
43,134
$5.61
$241,982
Sale
Common Stock
43,134
$54.75
$2,361,587
Option
Stock Option (Right to Buy)
43,134
$5.61
$241,982
Sale
Common Stock
43,134
$54.75
$2,361,587
Option
Common Stock
43,134
$5.61
$241,982
Sale
Common Stock
25,000
N/A
N/A
Option
Stock Option (Right to Buy)
25,000
N/A
N/A
Sale
Common Stock
25,000
N/A
N/A
Option
Common Stock
25,000
$7.81
$195,125
Option
Common Stock
25,000
N/A
N/A
Option
Stock Option (Right to Buy)
25,000
$7.81
$195,125
Option
Stock Option (Right to Buy)
1,265
N/A
N/A
Sale
Common Stock
75,000
N/A
N/A
Sale
Common Stock
75,000
$58.38
$4,378,350
Option
Common Stock
1,265
N/A
N/A
Option
Common Stock
16,000
N/A
N/A
Sale
Common Stock
7,258
N/A
N/A
Option
Performance-Based Restricted Stock Units
8,000
N/A
N/A
Sale
Common Stock
7,258
$51.74
$375,536
Sale
Common Stock
4,541
N/A
N/A
Option
Common Stock
13,043
N/A
N/A
Option
Performance-Based Restricted Stock Units
13,043
N/A
N/A
Option
Stock Option (Right to Buy)
709
$1.63
$1,156
Option
Common Stock
709
$1.63
$1,156
Sale
Common Stock
709
$1.63
$1,156
Option
Common Stock
45,000
$1.46
$65,565
Option
Stock Option (Right to Buy)
45,000
$1.46
$65,565
Sale
Common Stock
45,000
$38.11
$1,714,995
Sale
Common Stock
30,000
$39.26
$1,177,890
Option
Common Stock
30,000
$1.37
$41,100
Option
Stock Option (Right to Buy)
30,000
$1.37
$41,100
Sale
Common Stock
15,000
$40.05
$600,780
Option
Stock Option (Right to Buy)
15,000
N/A
N/A
Option
Common Stock
15,000
$40.05
$600,780
Sale
Common Stock
15,000
$40.05
$600,780
Option
Stock Option (Right to Buy)
15,000
$40.05
$600,780
Option
Common Stock
15,000
$40.05
$600,780
Option
Common Stock
30,000
$1.15
$34,500
Sale
Common Stock
30,000
$40.05
$1,201,560
Option
Stock Option (Right to Buy)
30,000
$1.15
$34,500
Option
Common Stock
20,000
$0.98
$19,600
Option
Stock Option (Right to Buy)
20,000
$0.98
$19,600
Sale
Common Stock
20,000
$34.36
$687,140
Sale
Common Stock
30,000
$23.33
$699,810
Option
Stock Option (Right to Buy)
30,000
$0.98
$29,400
Option
Common Stock
30,000
$0.98
$29,400
Option
Stock Option (Right to Buy)
8,294
$0.98
$8,128
Option
Common Stock
8,294
$0.98
$8,128
Sale
Common Stock
8,294
$0.98
$8,128
Sale
Common Stock
31,706
$28
$887,768
Option
Stock Option (Right to Buy)
23,853
$0.98
$23,376
Option
Common Stock
23,853
$0.98
$23,376
Sale
Common Stock
40,000
$34.25
$1,370,000
Option
Common Stock
20,103
$0.98
$19,701
Sale
Common Stock
206
$34
$7,004
Option
Stock Option (Right to Buy)
20,103
$0.98
$19,701
Option
Performance-Based Restricted Stock Units
8,000
N/A
N/A
Option
Common Stock
8,000
N/A
N/A
Sale
Common Stock
40,000
$16.22
$648,760
Option
Common Stock
20,000
$0.98
$19,600
Option
Stock Option (Right to Buy)
20,000
$0.98
$19,600
Sale
Common Stock
30,000
$26.07
$782,100
Sale
Common Stock
30,000
$21.61
$648,240
Sale
Common Stock
30,000
$20.74
$622,050
Axonics key executives
Axonics, Inc. executives and other stock owners filed with the SEC: